Clinical Trial Update: Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, docetaxel, and radiation therapy for stage III/IV or recurrent endometrial cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2010-11-11